SciELO - Scientific Electronic Library Online

 
vol.24 número3Early use of atropine in dobutamine stress echocardiogramGenotypic and phenotypic differences between genders: Cardiology for women índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Medicas UIS

versão impressa ISSN 0121-0319

Resumo

ALVAREZ-ORTIZ, Alexander et al. Therapy after the implant of cardioverter-defibrillator in the primary and secundary prevention of sudden death during the first year of follow up in the a clinic of fourth level of complexity.. Medicas UIS [online]. 2011, vol.24, n.3, pp.253-263. ISSN 0121-0319.

Introduction: the implant of cardioverter-defibrillator has changes the pronostic in the primary and secondary prevention in the patients with suden death. There are a lot of evidence that supports that the therapies of the CDI (antitachycardia and shocks) have impact on the morbimortality of the patients with Implantable Cardioverter-Defibrillators, besides the effect proarritmogenic. Objective: It is for determining which is the incidence of appropriate and inappropriate therapies in our population of patients with Implantable Cardioverter-Defibrillators for primary and secondary prevention of sudden death. Materials and Methods: we describe a case series of patients with cardioverter-defibrillator as the primary and secondary prevention of sudden death in a clinic of fourth level of complexity. Results: the incidence of therapy of the Implantable Cardioverter-Defibrillators after implant in patients with primary and secondary prevention of sudden death to the first year of follow-up was 44 %. The incidence of apropiate therapy of the Implantable Cardioverter-Defibrillators after implant in patients with primary prevention of sudden death to the first year of follow-up was the 26,3 %.The incidence of apropiate therapy of the Implantable Cardioverter-Defibrillators after implant in patients with secondary prevention of sudden death to the first year of follow-up was the 53 %. The half of the patients with Implantable Cardioverter-Defibrillators afterimpant for primary prevention or secondary had apropiate therapies during the first year of follow - up.36 % of the patients presented inappropriate therapies during the year of follow-up after first implat of the Implantable Cardioverter-Defibrillators. Conclusions: The therapies after to the implant of cardioverter-Defibrillator were near to the half of the patients, being more frecuent in the secundary prevention. These events may be present in the different pathologies , and to be apropiate and inapropiate. The complications of procedure may be acutes and chronics. (MÉD.UIS. 2011;24(3):253-63).

Palavras-chave : Implantable Cardioverter-Defibrillators; Sudden death; Primary prevention; Secondary prevention; Antitachycardia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )